Literature DB >> 10857162

The lymph node as a bridgehead in the metastatic dissemination of tumors.

J P Sleeman1.   

Abstract

The metastatic spread of tumors is not a random process. Distinct patterns of metastasis can be discerned which vary from tumor type to tumor type. A common pattern, particularly for carcinomas, is that regional lymph nodes are often the first organs to develop metastases. This pattern of metastasis is central to the utility of the sentinel lymphonodectomy surgical technique. However, not all tumors and tumor types metastasize first to the regional lymph nodes. The mechanisms which determine whether regional lymph nodes or other sites first develop metastases remain poorly understood. In this article I review the anatomical, cellular and molecular factors which play a role in metastatic dissemination and determine patterns of metastasis. I then explore the importance of tumor heterogeneity and the selection of metastatically competent tumor cells during systemic dissemination, and suggest that some secondary sites are more readily colonised by metastasizing cells than others. Metastases at these sites act as bridgeheads, constituting a reservoir of tumor cells which, because they have already successfully metastasized, possess many of the properties required for metastasis to further sites. These tumor cells are therefore more likely than cells in the primary tumor to acquire all of the properties required for metastasis to less favourable secondary sites. To illustrate the bridgehead concept, I argue that features of the design and function of the lymphatic system make it highly amenable to the entry of metastasizing tumor cells and the formation of lymph node metastases, and suggest that lymph node metastases form a bridgehead for further metastatic spread.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10857162     DOI: 10.1007/978-3-642-57151-0_6

Source DB:  PubMed          Journal:  Recent Results Cancer Res        ISSN: 0080-0015


  60 in total

Review 1.  The connectivity of lymphogenous and hematogenous tumor cell dissemination: biological insights and clinical implications.

Authors:  Jonathan P Sleeman; Blake Cady; Klaus Pantel
Journal:  Clin Exp Metastasis       Date:  2012-06-06       Impact factor: 5.150

2.  Construction and selection of subtracted cDNA library of mouse hepatocarcinoma cell lines with different lymphatic metastasis potential.

Authors:  Li Hou; Jan-Wu Tang; Xiao-Nan Cui; Bo Wang; Bo Song; Lei Sun
Journal:  World J Gastroenterol       Date:  2004-08-15       Impact factor: 5.742

3.  Malnutrition alters the innate immune response and increases early visceralization following Leishmania donovani infection.

Authors:  G M Anstead; B Chandrasekar; W Zhao; J Yang; L E Perez; P C Melby
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

4.  Pre-metastatic conditioning of organ microenvironments by tumors: beyond preparing the soil.

Authors:  Jonathan P Sleeman
Journal:  J Mol Med (Berl)       Date:  2015-11       Impact factor: 4.599

Review 5.  Lymphatic or hematogenous dissemination: how does a metastatic tumor cell decide?

Authors:  Sunny Y Wong; Richard O Hynes
Journal:  Cell Cycle       Date:  2006-04-17       Impact factor: 4.534

Review 6.  Drug delivery to the lymphatic system: importance in future cancer diagnosis and therapies.

Authors:  Yumei Xie; Taryn R Bagby; M S Cohen; M Laird Forrest
Journal:  Expert Opin Drug Deliv       Date:  2009-08       Impact factor: 6.648

7.  FoxM1 influences mouse hepatocellular carcinoma metastasis in vitro.

Authors:  Ningning Zhang; Yunpeng Xie; Benke Li; Zhen Ning; Aman Wang; Xiaonan Cui
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

8.  Clinicopathological significance of MMP-7, laminin γ2 and EGFR expression at the invasive front of gastric carcinoma.

Authors:  Kazuhiro Sentani; Miho Matsuda; Naohide Oue; Naohiro Uraoka; Yutaka Naito; Naoya Sakamoto; Wataru Yasui
Journal:  Gastric Cancer       Date:  2013-09-19       Impact factor: 7.370

Review 9.  Lymphatic metastasis in breast cancer: importance and new insights into cellular and molecular mechanisms.

Authors:  Suzanne Eccles; Lenaic Paon; Jonathan Sleeman
Journal:  Clin Exp Metastasis       Date:  2007-11-06       Impact factor: 5.150

Review 10.  Mammary cancer gene therapy targeting lymphangiogenesis: VEGF-C siRNA and soluble VEGF receptor-2, a splicing variant.

Authors:  Masa-Aki Shibata; Jayakrishna Ambati; Eiko Shibata; Katsuhide Yoshidome; Mariko Harada-Shiba
Journal:  Med Mol Morphol       Date:  2012-12-07       Impact factor: 2.309

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.